| 1 |
Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005; 24:761-5. |
미소장 |
| 2 |
Cherry JD. Epidemic pertussis in 2012: the resurgence of a vaccine-preventable disease. N Engl J Med 2012; 367:785-7. |
미소장 |
| 3 |
Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013; 13:151. |
미소장 |
| 4 |
Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Vaccine 2012; 30:5179-90. |
미소장 |
| 5 |
Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11:557-70. |
미소장 |
| 6 |
Kmietowicz Z. Pertussis cases rise 10-fold among older children and adults in England and Wales. BMJ 2012; 345: e5008. |
미소장 |
| 7 |
Why do pertussis vaccines fail?  |
미소장 |
| 8 |
Pertussis immunization in a high-risk postpartum population  |
미소장 |
| 9 |
Xing D, Wirsing von Konig CH, Newland P, et al. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin Vaccine Immunol 2009; 16:303-11. |
미소장 |
| 10 |
European Centre for Disease Prevention and Control. Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis. Stockholm: European Centre for Disease Prevention and Control; 2012. |
미소장 |
| 11 |
Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Mollby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 1995; 183:279-90. |
미소장 |
| 12 |
Baughman AL, Bisgard KM, Edwards KM, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004; 11:1045-53. |
미소장 |
| 13 |
Andre P, Caro V, Njamkepo E, Wendelboe AM, Van Rie A, Guiso N. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J Clin Microbiol 2008; 46:1672-7. |
미소장 |
| 14 |
Guiso N, Berbers G, Fry NK, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011; 30:307-12. |
미소장 |
| 15 |
Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model.  |
미소장 |
| 16 |
The crystal structure of pertussis toxin.  |
미소장 |
| 17 |
Katada T, Ui M. ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem 1982; 257:7210-6. |
미소장 |
| 18 |
Locht C, Coutte L, Mielcarek N. The ins and outs of pertussis toxin. FEBS J 2011; 278:4668-82. |
미소장 |
| 19 |
Funnell SG, Robinson A. A novel adherence assay for Bordetella pertussis using tracheal organ cultures. FEMS Microbiol Lett 1993; 110:197-203. |
미소장 |
| 20 |
Ishibashi Y, Nishikawa A. Bordetella pertussis infection of human respiratory epithelial cells up-regulates intercellular adhesion molecule-1 expression: role of filamentous hemagglutinin and pertussis toxin. Microb Pathog 2002; 33: 115-25. |
미소장 |
| 21 |
Melvin JA, Scheller EV, Miller JF, Cotter PA. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol 2014; 12:274-88. |
미소장 |
| 22 |
Carbonetti NH. Bordetella pertussis: new concepts in pathogenesis and treatment. Curr Opin Infect Dis 2016; 29: 287-94. |
미소장 |
| 23 |
Hovingh ES, Mariman R, Solans L, et al. Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor. Emerg Microbes Infect 2018; 7:39. |
미소장 |